ArticleBMJ case reports2018

Treatment dilemma for survivors of rituximab-induced bowel perforation in the setting of post-transplant lymphoproliferative disorder.

Brianne J Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.